Responses to medical treatment in patients with metastatic unresectable small intestinal neuroendocrine tumors – A single center study of 378 patients

Documenti analoghi

• Controversies in neuroendocrine neoplasms: An European Neuroendocrine Tumor Society position statement on the role of surgery of the primary tumour in metastatic small intestinal and pancreatic neuroendocrine tumours
  di: Stefano Partelli, et al.
  Pubblicazione: (2026)
• Follow‐up is not justified in patients with typical lung carcinoids without lymph node involvement treated with curative intent: A Danish Multi‐ENETS Center of Excellence Study
  di: Tobias Stemann Lau, et al.
  Pubblicazione: (2026)
• Biomarker‐directed aptamer panels for diagnosis and differentiation of neuroendocrine tumors
  di: Mikkel Breinholt Kjær, et al.
  Pubblicazione: (2026)
• Role of neoadjuvant peptide receptor radionuclide therapy in unresectable and metastatic gastro‐entero‐pancreatic neuroendocrine neoplasms: A scoping review
  di: Raghava Kashyap, et al.
  Pubblicazione: (2024)
• Impact on symptoms and survival of bone metastases in patients with small‐intestinal neuroendocrine tumours
  di: Maria Wedin, et al.
  Pubblicazione: (2025)